TR199801126T2 - Tolfenamik asit veya bunun farmasötik açidan kabul edilebilir bir tuzunu içeren hizli tahliye edici tablet. - Google Patents

Tolfenamik asit veya bunun farmasötik açidan kabul edilebilir bir tuzunu içeren hizli tahliye edici tablet.

Info

Publication number
TR199801126T2
TR199801126T2 TR1998/01126T TR9801126T TR199801126T2 TR 199801126 T2 TR199801126 T2 TR 199801126T2 TR 1998/01126 T TR1998/01126 T TR 1998/01126T TR 9801126 T TR9801126 T TR 9801126T TR 199801126 T2 TR199801126 T2 TR 199801126T2
Authority
TR
Turkey
Prior art keywords
pharmaceutically acceptable
quick
acceptable salt
release tablet
tablet containing
Prior art date
Application number
TR1998/01126T
Other languages
English (en)
Inventor
Erik Gebhard-Hansen Knud
Bjornsdottir Karen
Hedevang Christensen Lars
Bols Pedersen Soren
Original Assignee
A/S Gea Farmaceutisk Fabrik
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A/S Gea Farmaceutisk Fabrik filed Critical A/S Gea Farmaceutisk Fabrik
Publication of TR199801126T2 publication Critical patent/TR199801126T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Tolfenamik asit ve bunun farmasötik açidan kabul edilebilir tuzlarindan seçilmis bir aktif bilesen ihtiva eden hizli tahliye edici bir tablet. Aktif bilesen 10 um'ye esit veya daha küçük bir ortalama tanecik boyuna sahiptir. Bu tablet agirlikça %1.5'den %6.0'ya kadar bir miktarda aljinik asit veya bunun farmasötik açidan kabul edilebilir bir tuzunu, ve agirlikça en az %6'lik bir miktarda bir süper ayristirici ihtiva eder.
TR1998/01126T 1995-12-20 1996-12-19 Tolfenamik asit veya bunun farmasötik açidan kabul edilebilir bir tuzunu içeren hizli tahliye edici tablet. TR199801126T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK144895 1995-12-20

Publications (1)

Publication Number Publication Date
TR199801126T2 true TR199801126T2 (tr) 1998-08-21

Family

ID=8104933

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/01126T TR199801126T2 (tr) 1995-12-20 1996-12-19 Tolfenamik asit veya bunun farmasötik açidan kabul edilebilir bir tuzunu içeren hizli tahliye edici tablet.

Country Status (27)

Country Link
US (1) US6036975A (tr)
EP (1) EP0869783B1 (tr)
JP (1) JP2000515489A (tr)
CN (1) CN1147295C (tr)
AR (1) AR004395A1 (tr)
AT (1) ATE234085T1 (tr)
AU (1) AU1190097A (tr)
BR (1) BR9612057A (tr)
CA (1) CA2244396A1 (tr)
CZ (1) CZ293422B6 (tr)
DE (1) DE69626676T2 (tr)
DK (1) DK0869783T3 (tr)
EE (1) EE9800186A (tr)
ES (1) ES2191781T3 (tr)
HR (1) HRP960598A2 (tr)
HU (1) HU224030B1 (tr)
IL (1) IL124356A (tr)
MX (1) MX9803918A (tr)
NO (1) NO316869B1 (tr)
NZ (1) NZ324674A (tr)
PL (1) PL186915B1 (tr)
RO (1) RO117589B1 (tr)
RU (1) RU2166939C2 (tr)
TR (1) TR199801126T2 (tr)
TW (1) TW430561B (tr)
WO (1) WO1997022340A1 (tr)
ZA (1) ZA9610714B (tr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802973D0 (sv) 1998-09-03 1998-09-03 Astra Ab Immediate release tablet
US6599530B2 (en) * 1998-09-14 2003-07-29 Orion Corporation Oral compacted composition comprising catechol derivatives
US6660303B2 (en) * 1999-12-06 2003-12-09 Edward Mendell & Co. Pharmaceutical superdisintegrant
CA2311734C (en) * 2000-04-12 2011-03-08 Bristol-Myers Squibb Company Flash-melt oral dosage formulation
WO2005028621A2 (en) * 2003-09-15 2005-03-31 Vitra Bioscience, Inc. Assays with primary cells
WO2007112098A2 (en) * 2006-03-24 2007-10-04 The Texas A & M University System And Safe Et Al Uses of diphenyl/diphenylamine carboxylic acids
TWI405574B (zh) * 2007-06-21 2013-08-21 Otsuka Pharma Co Ltd 藥學固體製劑及其製造方法
US8367427B2 (en) * 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
CA3036053A1 (en) * 2016-09-07 2018-03-15 Celgene Corporation Tablet compositions
CN111184707B (zh) * 2020-02-20 2021-04-27 中山大学 托芬那酸或其药学上可接受的盐在制备预防和/或治疗新型冠状病毒炎症药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE116061C (tr) *
FI89004C (fi) * 1988-02-16 1993-08-10 Pertti J Neuvonen Anvaendning av tillsatsmedel foer oekning av absorptionshastigheten av laekemedel i orala laekemedelspreparat
IT1276689B1 (it) * 1995-06-09 1997-11-03 Applied Pharma Res Forma farmaceutica solida ad uso orale

Also Published As

Publication number Publication date
PL327584A1 (en) 1998-12-21
AU1190097A (en) 1997-07-14
AR004395A1 (es) 1998-11-04
CZ194398A3 (cs) 1998-11-11
HU224030B1 (hu) 2005-05-30
IL124356A0 (en) 1998-12-06
IL124356A (en) 2001-05-20
ATE234085T1 (de) 2003-03-15
NO316869B1 (no) 2004-06-07
EP0869783A1 (en) 1998-10-14
CN1208345A (zh) 1999-02-17
PL186915B1 (pl) 2004-03-31
HUP9903410A3 (en) 2000-05-29
ES2191781T3 (es) 2003-09-16
JP2000515489A (ja) 2000-11-21
CA2244396A1 (en) 1997-06-26
NO982875L (no) 1998-08-19
BR9612057A (pt) 1999-02-23
DE69626676T2 (de) 2003-12-18
NZ324674A (en) 2000-01-28
HUP9903410A2 (hu) 2000-04-28
RO117589B1 (ro) 2002-05-30
NO982875D0 (no) 1998-06-19
CN1147295C (zh) 2004-04-28
RU2166939C2 (ru) 2001-05-20
WO1997022340A1 (en) 1997-06-26
EE9800186A (et) 1998-12-15
HRP960598A2 (en) 1998-02-28
MX9803918A (es) 1998-09-30
EP0869783B1 (en) 2003-03-12
DE69626676D1 (de) 2003-04-17
US6036975A (en) 2000-03-14
ZA9610714B (en) 1997-06-30
CZ293422B6 (cs) 2004-04-14
TW430561B (en) 2001-04-21
DK0869783T3 (da) 2003-06-02

Similar Documents

Publication Publication Date Title
ATE197124T1 (de) Wirkstoffe und gas enthaltende mikropartikel
EP1137403A4 (en) A HYDROCOLLOID AND A DELIVERY-RELATED TABLET CONTAINING CELLULOSE ETHER
FI973320A (fi) Kiinteitä aktiiviainetta sisältäviä valmisteita
ATE239454T1 (de) Orale morphinzubereitung in teilchenform
ATE229327T1 (de) Verwendung von redispergierbaren polymerpulvern oder polymergranulaten zum überziehen von pharmazeutischen oder agrochemischen darreichungsformen
DE3581819D1 (de) Pyridazinamine wirksam gegen viren.
HRP20010463B1 (en) Controlled release galantamine composition
CA2286482A1 (en) Nkt cell-activating agents containing .alpha.-glycosylceramides
DE59908764D1 (de) Agitationsunabhängige pharmazeutische multiple-unit-retardzubereitungen und verfahren zu ihrer herstellung
TR199801126T2 (tr) Tolfenamik asit veya bunun farmasötik açidan kabul edilebilir bir tuzunu içeren hizli tahliye edici tablet.
DE69812949D1 (de) Hydroxamsäurederivat und antitumormittel enthaltende pharmazeutische zusammensetzung mit verbesserter antitumor-aktivität und/oder verringerten nebenwirkungen
DE3886986D1 (de) Glykoprotein, Verfahren zu dessen Herstellung und dieses als aktiven Bestandteil enthaltendes immunsuppressives Agens.
ES2173595T3 (es) Encapsulado de ingredientes activos.
NO995127D0 (no) Stabiliserte tibolonblandinger
DE59810803D1 (de) Kontrolliert freisetzende pharmazeutische zubereitung mit einem ace-hemmer als wirkstoff
IT1272149B (it) Composizione farmeceutiche ad attivita' analgesica
ATE68686T1 (de) System zum freigeben von stoffen in der vagina.
PT1091740E (pt) Preparacoes aquosas semi-solidas para administracao oral de toltrazuril-sulfona
DK1105099T3 (da) Sammensætning af fiskegelatine til brug som ingrediens i tabletter
BG94934A (bg) Твърди лекарствени форми за орално приложение,съдържащи ифосфамид като активно вещество
MX9709453A (es) Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion.
MA26447A1 (fr) Analogues peptidiques de la lh-rh, leurs utilisations et compositions pharmaceutiques en contenant
CA2269502A1 (en) Tetraether lipid derivatives and liposomes and lipid agglomerates containing tetraetherlipid derivatives, and use thereof
CA2360418A1 (en) Spheronised self-emulsifying system for hydrophobic and water-sensitive agents
HUP9700455A1 (hu) 3-Fenil-4-hidroxi-6-klór-piridazin hatóanyagot tartalmazó gyomirtó készítmények, és eljárás gyomok irtására